About 20% Of Patients With COVID-19 Experienced Virologic Rebound After Receiving Nirmatrelvir/Ritonavir, Study Finds

November 14, 2023

Healio (11/13, Rhoades) reports, “About 20% of patients with COVID-19 experienced virologic rebound after receiving Paxlovid, according to an observational study published in Annals of Internal Medicine.” Prior “research has suggested that viral RNA rebou...